HTG Molecular to Raise $800K in Private Financing | GenomeWeb

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics said in a regulatory filing this week that it aims to raise $800,000 through a private offering of stock.

The Tucson, Ariz.-based firm declined to comment on the financing, but in a document filed with the US Securities and Exchange Commission, it said that there are two investors in the round, which comprised an option, warrant, or other right to acquire another security, as well as security to be acquired upon the exercise of an option, warrant, or other right to acquire security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.